Physician

Joshua Priluck, M.D.

According to 2025 Medicare claims, Joshua Priluck, M.D. (NPI: 1932360914) practices ophthalmology in the Omaha, NE-IA market, with the plurality of this provider's patient population coming from Douglas, NE. This provider's primary affiliated billing organization is RETINA CONSULTANTS OF THE MIDLANDS PC (NPI: 1346338092; TIN: 470628387) and primary practice location at 68114-4762.

Priluck's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,143 traditional Medicare patients, billed 44,431 HCPCS/CPT codes, and received $2,529,393 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 444 prescription claims across 141 beneficiaries totaling $28,026 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 2 records totaling $157. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,207,534 to $2,529,393. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.5M2015 Medicare payment: $1,207,534 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,398,432 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,382,599 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,365,132 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,623,728 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,650,624 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,894,444 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,832,142 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,261,555 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,529,393 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201599810,739$1,207,534
201699011,245$1,398,432
20171,08110,900$1,382,599
20181,05610,967$1,365,132
20191,15911,229$1,623,728
20201,0609,830$1,650,624
20211,11510,741$1,894,444
20221,08410,314$1,832,142
20231,13029,116$2,261,555
20241,14344,431$2,529,393

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$24K$48K2015 Drug cost: $32,463 (USD; Tot_Drug_Cst)2016 Drug cost: $34,935 (USD; Tot_Drug_Cst)2017 Drug cost: $36,104 (USD; Tot_Drug_Cst)2018 Drug cost: $41,608 (USD; Tot_Drug_Cst)2019 Drug cost: $41,564 (USD; Tot_Drug_Cst)2020 Drug cost: $37,132 (USD; Tot_Drug_Cst)2021 Drug cost: $37,777 (USD; Tot_Drug_Cst)2022 Drug cost: $48,140 (USD; Tot_Drug_Cst)2023 Drug cost: $34,500 (USD; Tot_Drug_Cst)2024 Drug cost: $28,026 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015340709$32,463
2016301731$34,935
2017183557$36,104
2018186618$41,608
2019143459$41,564
2020136428$37,132
2021148453$37,777
2022147550$48,140
2023161526$34,500
2024141444$28,026

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system232232$100
92014Established patient complete exam of visual system9101,109$82
67028Injection of drug into eye3891,582$82
92012Established patient problem focused exam of visual system487823$60
92134Imaging of retina9282,506$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine13495$8,582
CombiganBrimonidine Tartrate/Timolol14680$4,704
Prednisolone AcetatePrednisolone Acetate642,133$2,225
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat573,860$1,101
Ketorolac TromethamineKetorolac Tromethamine632,037$925

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$157Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Joshua Priluck, M.D.?

Tedicare shows public-source Medicare data for Joshua Priluck, M.D. (NPI 1932360914), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joshua Priluck, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Joshua Priluck, M.D.?

Joshua Priluck, M.D. is linked to RETINA CONSULTANTS OF THE MIDLANDS PC (billing NPI 1346338092) in the available physician profile data.

Does Joshua Priluck, M.D. have Open Payments data?

Joshua Priluck, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.